Shay Laps
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shay Laps has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ashraf Brik
Schulich Faculty of Chemistry, Technion – Israel Institute of Technology, Haifa, Israel
11 shared publications Guy Kamnesky
Schulich Faculty of Chemistry Technion-Israel Institute of Technology Haifa 3200008 Israel
8 shared publications- Fatima Atamleh
Schulich Faculty of Chemistry Technion-Israel Institute of Technology Haifa 3200008 Israel
3 shared publications Muhammad Jbara
Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa, 3200008, Israel
3 shared publications- Norman Metanis
Institute of Chemistry The Center for Nanoscience and Nanotechnology Casali Center of Applied Chemistry The Hebrew University of Jerusalem Jerusalem 9190401 Israel
3 shared publications - Suman Kumar Maity
Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa, 3200008, Israel
3 shared publications
Latest Publications
- Open Access
- 20 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Towards smart insulin development bearing rigid synthetic-diboronate chemistry applying de novo Protein Specific Modification
Insulin – a hormone, a medication, and protein – is one of the most fascinating and influential molecules ever discovered. Scientific understanding of insulin and the ability to adapt it for medical needs cross boundaries of knowledge, technology, and research. For hundreds of millions of people living with diabetes around the world, it is not only a scientific achievement but an urgent necessity – a vital solution that saves lives every single day. The chemical functionalization of insulin has been desired for various applications such as controlled release (e.g. short or long acting), rescue from toxic fibrillation, and searching for alternative administration approaches (e.g. oral medication). In Type-1 diabetes the controlled pancreas mediated secretion of insulin is been diminished, raising the need to apply insulin to the blood circulation on demand and careful control. With the risk of hypoglycemia attempts are being explored continuously to develop chemistry for the rewiring of insulin properties towards gaining an unnatural sensitivity to glucose blood levels, mimicking the failed pancreatic control. Due to their sugars binding capabilities, boronic acids are great candidates for potential insulin built-in glucose molecular sensors. Nevertheless, despite a century of scientific research the synthetic information currently available for multiple and selective insulin modification is inadequate, limiting the possibility to explore the effect of sensitive functional groups implantation into insulin. Moreover, boronic acid compounds were discovered to be less potent towards glucose rather than other sugars (e.g. fructose), limiting its therapeutic potential. Here, we report the development of a de novo Protein Specific Modification (PSM) strategy. The strategy focuses on shifting the paradigm from general-to-specific protein modification protocols. We revealed and utilized a new synthetic kit to perform multiple insulin modification in a precise manner. Utilizing our developed protocol, we were able to modify naked insulin precisely with three different elements. Moreover, we have progressed towards the potential development of smart boronate insulin by the introduction of synthetic rigid diborontae motif with glucose sensitive properties. Also, we have inserted a glucose mimic element to explore potential activity changes upon internal reversible bridging in presence and absence of glucose. Our in-cell activities findings reveal surprised tolerance of two de novo insulin analogues to a fluctuation with sugars levels. We anticipate these findings to pave the way for the further exploration of synthetic diboronate chemistry in the context of insulin modification. In addition, we expect our PSM approach for targeting a solely protein or a member of large protein family to transform the field of protein chemistry, allowing precise tools for more focused aims, with tremendous therapeutic potential and scope. This paradigm shifts from the general to the specific targeted chemistry in peptide and protein science is anticipated to open the door for a future database, we term as; PSM bank, to modify specific protein in the presence of other peptide and proteins, potentially for in vivo spatial selectivity.
- 20 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessTowards smart insulin development bearing rigid synthetic-diboronate chemistry applying de novo Protein Specific Modification
Insulin – a hormone, a medication, and protein – is one of the most fascinating and influential molecules ever discovered. Scientific understanding of insulin and the ability to adapt it for medical needs cross boundaries of knowledge, technology, and research. For hundreds of millions of people living with diabetes around the world, it is not only a scientific achievement but an urgent necessity – a vital solution that saves lives every single day. The chemical functionalization of insulin has been desired for various applications such as controlled release (e.g. short or long acting), rescue from toxic fibrillation, and searching for alternative administration approaches (e.g. oral medication). In Type-1 diabetes the controlled pancreas mediated secretion of insulin is been diminished, raising the need to apply insulin to the blood circulation on demand and careful control. With the risk of hypoglycemia attempts are being explored continuously to develop chemistry for the rewiring of insulin properties towards gaining an unnatural sensitivity to glucose blood levels, mimicking the failed pancreatic control. Due to their sugars binding capabilities, boronic acids are great candidates for potential insulin built-in glucose molecular sensors. Nevertheless, despite a century of scientific research the synthetic information currently available for multiple and selective insulin modification is inadequate, limiting the possibility to explore the effect of sensitive functional groups implantation into insulin. Moreover, boronic acid compounds were discovered to be less potent towards glucose rather than other sugars (e.g. fructose), limiting its therapeutic potential. Here, we report the development of a de novo Protein Specific Modification (PSM) strategy. The strategy focuses on shifting the paradigm from general-to-specific protein modification protocols. We revealed and utilized a new synthetic kit to perform multiple insulin modification in a precise manner. Utilizing our developed protocol, we were able to modify naked insulin precisely with three different elements. Moreover, we have progressed towards the potential development of smart boronate insulin by the introduction of synthetic rigid diborontae motif with glucose sensitive properties. Also, we have inserted a glucose mimic element to explore potential activity changes upon internal reversible bridging in presence and absence of glucose. Our in-cell activities findings reveal surprised tolerance of two de novo insulin analogues to a fluctuation with sugars levels. We anticipate these findings to pave the way for the further exploration of synthetic diboronate chemistry in the context of insulin modification. In addition, we expect our PSM approach for targeting a solely protein or a member of large protein family to transform the field of protein chemistry, allowing precise tools for more focused aims, with tremendous therapeutic potential and scope. This paradigm shifts from the general to the specific targeted chemistry in peptide and protein science is anticipated to open the door for a future database, we term as; PSM bank, to modify specific protein in the presence of other peptide and proteins, potentially for in vivo spatial selectivity.
- 18 April 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (5) , 680-681
Organic solvent enhances oxidative folding of disulfide-rich proteins
- 18 April 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (5) , 680-681
Organic solvent enhances oxidative folding of disulfide-rich proteins
- 22 February 2024
- Published by Springer Nature in Nature Reviews Chemistry
- Vol. 8 (3) , 211-229
Selenium chemistry for spatio-selective peptide and protein functionalization
The ability to construct a peptide or protein in a spatio-specific manner is of great interest for therapeutic and biochemical research. However, the various functional groups present in peptide sequences and the need to perform chemistry under mild and aqueous conditions make selective protein functionalization one of the greatest synthetic challenges. The fascinating paradox of selenium (Se) — being found in both toxic compounds and also harnessed by nature for essential biochemical processes — has inspired the recent exploration of selenium chemistry for site-selective functionalization of peptides and proteins. In this Review, we discuss such approaches, including metal-free and metal-catalysed transformations, as well as traceless chemical modifications. We report their advantages, limitations and applications, as well as future research avenues.
- 22 February 2024
- Published by Springer Nature in Nature Reviews Chemistry
- Vol. 8 (3) , 211-229
Selenium chemistry for spatio-selective peptide and protein functionalization
The ability to construct a peptide or protein in a spatio-specific manner is of great interest for therapeutic and biochemical research. However, the various functional groups present in peptide sequences and the need to perform chemistry under mild and aqueous conditions make selective protein functionalization one of the greatest synthetic challenges. The fascinating paradox of selenium (Se) — being found in both toxic compounds and also harnessed by nature for essential biochemical processes — has inspired the recent exploration of selenium chemistry for site-selective functionalization of peptides and proteins. In this Review, we discuss such approaches, including metal-free and metal-catalysed transformations, as well as traceless chemical modifications. We report their advantages, limitations and applications, as well as future research avenues.
- Open Access
- 24 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 14 (44) , 12723-12729
The semisynthesis of nucleolar human selenoprotein H
The human selenoprotein H is the only selenocysteine-containing protein that is located in the cell's nucleolus. In vivo studies have suggested that it plays some role in DNA binding, consumption of reactive oxygen species, and may serve as a safeguard against cancers. However, the protein has never been isolated and, as a result, not yet fully characterized. Here, we used a semi-synthetic approach to obtain the full selenoprotein H with a S43T mutation. Using biolayer interferometry, we also show that the Cys-containing mutant of selenoprotein H is capable of binding DNA with sub-micromolar affinity. Employing state-of-the-art expressed protein ligation (EPL), our devised semi-synthetic approach can be utilized for the production of numerous, hard-to-obtain proteins of biological and therapeutic relevance.
- 24 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 14 (44) , 12723-12729
Open AccessThe semisynthesis of nucleolar human selenoprotein H
The human selenoprotein H is the only selenocysteine-containing protein that is located in the cell's nucleolus. In vivo studies have suggested that it plays some role in DNA binding, consumption of reactive oxygen species, and may serve as a safeguard against cancers. However, the protein has never been isolated and, as a result, not yet fully characterized. Here, we used a semi-synthetic approach to obtain the full selenoprotein H with a S43T mutation. Using biolayer interferometry, we also show that the Cys-containing mutant of selenoprotein H is capable of binding DNA with sub-micromolar affinity. Employing state-of-the-art expressed protein ligation (EPL), our devised semi-synthetic approach can be utilized for the production of numerous, hard-to-obtain proteins of biological and therapeutic relevance.
- 15 September 2021
- Published by Wiley in Angewandte Chemie
- Vol. 133 (45) , 24339-24345
Insight on the Order of Regioselective Ultrafast Formation of Disulfide Bonds in (Antimicrobial) Peptides and Miniproteins
Disulfide‐rich peptides and proteins are among the most fascinating bioactive molecules. The difficulties associated with the preparation of these targets have prompted the development of various chemical strategies. Nevertheless, the production of these targets remains very challenging or elusive. Recently, we introduced a strategy for one‐pot disulfide bond formation, tackling most of the previous limitations. However, the effect of the order of oxidation remained an underexplored issue. Herein we report on the complete synthetic flexibility of the approach with respect to the order of oxidation of three disulfide bonds in targets that lack the knot motif. In contrast, our study reveals an essential order of disulfide bond formation in the EETI‐II knotted miniprotein. This synthetic strategy was applied for the synthesis of novel analogues of the plectasin antimicrobial peptide with enhanced activities against methicillin‐resistant Staphylococcus aureus (MRSA), a notorious human pathogen.
- 15 September 2021
- Published by Wiley in Angewandte Chemie
- Vol. 133 (45) , 24339-24345
Insight on the Order of Regioselective Ultrafast Formation of Disulfide Bonds in (Antimicrobial) Peptides and Miniproteins
Disulfide‐rich peptides and proteins are among the most fascinating bioactive molecules. The difficulties associated with the preparation of these targets have prompted the development of various chemical strategies. Nevertheless, the production of these targets remains very challenging or elusive. Recently, we introduced a strategy for one‐pot disulfide bond formation, tackling most of the previous limitations. However, the effect of the order of oxidation remained an underexplored issue. Herein we report on the complete synthetic flexibility of the approach with respect to the order of oxidation of three disulfide bonds in targets that lack the knot motif. In contrast, our study reveals an essential order of disulfide bond formation in the EETI‐II knotted miniprotein. This synthetic strategy was applied for the synthesis of novel analogues of the plectasin antimicrobial peptide with enhanced activities against methicillin‐resistant Staphylococcus aureus (MRSA), a notorious human pathogen.
- 15 September 2021
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (45) , 24137-24143
Insight on the Order of Regioselective Ultrafast Formation of Disulfide Bonds in (Antimicrobial) Peptides and Miniproteins
Disulfide‐rich peptides and proteins are among the most fascinating bioactive molecules. The difficulties associated with the preparation of these targets have prompted the development of various chemical strategies. Nevertheless, the production of these targets remains very challenging or elusive. Recently, we introduced a strategy for one‐pot disulfide bond formation, tackling most of the previous limitations. However, the effect of the order of oxidation remained an underexplored issue. Herein we report on the complete synthetic flexibility of the approach with respect to the order of oxidation of three disulfide bonds in targets that lack the knot motif. In contrast, our study reveals an essential order of disulfide bond formation in the EETI‐II knotted miniprotein. This synthetic strategy was applied for the synthesis of novel analogues of the plectasin antimicrobial peptide with enhanced activities against methicillin‐resistant Staphylococcus aureus (MRSA), a notorious human pathogen.
- 15 September 2021
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (45) , 24137-24143
Insight on the Order of Regioselective Ultrafast Formation of Disulfide Bonds in (Antimicrobial) Peptides and Miniproteins
Disulfide‐rich peptides and proteins are among the most fascinating bioactive molecules. The difficulties associated with the preparation of these targets have prompted the development of various chemical strategies. Nevertheless, the production of these targets remains very challenging or elusive. Recently, we introduced a strategy for one‐pot disulfide bond formation, tackling most of the previous limitations. However, the effect of the order of oxidation remained an underexplored issue. Herein we report on the complete synthetic flexibility of the approach with respect to the order of oxidation of three disulfide bonds in targets that lack the knot motif. In contrast, our study reveals an essential order of disulfide bond formation in the EETI‐II knotted miniprotein. This synthetic strategy was applied for the synthesis of novel analogues of the plectasin antimicrobial peptide with enhanced activities against methicillin‐resistant Staphylococcus aureus (MRSA), a notorious human pathogen.
- Open Access
- 8 February 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-9
General synthetic strategy for regioselective ultrafast formation of disulfide bonds in peptides and proteins
Despite six decades of efforts to synthesize peptides and proteins bearing multiple disulfide bonds, this synthetic challenge remains an unsolved problem in most targets (e.g., knotted mini proteins). Here we show a de novo general synthetic strategy for the ultrafast, high-yielding formation of two and three disulfide bonds in peptides and proteins. We develop an approach based on the combination of a small molecule, ultraviolet-light, and palladium for chemo- and regio-selective activation of cysteine, which enables the one-pot formation of multiple disulfide bonds in various peptides and proteins. We prepare bioactive targets of high therapeutic potential, including conotoxin, RANTES, EETI-II, and plectasin peptides and the linaclotide drug. We anticipate that this strategy will be a game-changer in preparing millions of inaccessible targets for drug discovery.
- 8 February 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-9
Open AccessGeneral synthetic strategy for regioselective ultrafast formation of disulfide bonds in peptides and proteins
Despite six decades of efforts to synthesize peptides and proteins bearing multiple disulfide bonds, this synthetic challenge remains an unsolved problem in most targets (e.g., knotted mini proteins). Here we show a de novo general synthetic strategy for the ultrafast, high-yielding formation of two and three disulfide bonds in peptides and proteins. We develop an approach based on the combination of a small molecule, ultraviolet-light, and palladium for chemo- and regio-selective activation of cysteine, which enables the one-pot formation of multiple disulfide bonds in various peptides and proteins. We prepare bioactive targets of high therapeutic potential, including conotoxin, RANTES, EETI-II, and plectasin peptides and the linaclotide drug. We anticipate that this strategy will be a game-changer in preparing millions of inaccessible targets for drug discovery.
- 12 January 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 50 (4) , 2367-2387
Harnessing the power of transition metals in solid-phase peptide synthesis and key steps in the (semi)synthesis of proteins
In this review, we highlight, summarize, and evaluate the use of various transition metals in the chemical synthesis of peptides and proteins with emphasis on recent developments in this exciting research area.
- 12 January 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 50 (4) , 2367-2387
Harnessing the power of transition metals in solid-phase peptide synthesis and key steps in the (semi)synthesis of proteins
In this review, we highlight, summarize, and evaluate the use of various transition metals in the chemical synthesis of peptides and proteins with emphasis on recent developments in this exciting research area.
- Open Access
- 8 October 2020
- Published by American Chemical Society (ACS) in ChemRxiv
De Novo Synthetic Design for Ultrafast Formation of Disulfide Bonds in Peptides and Proteins .pdf
Despite six decades of efforts to synthesize peptides and proteins bearing multiple disulfide bonds, this synthetic challenge remains an unsolved problem in most targets (e.g. knotted mini proteins). Here we show a de novo general synthetic strategy for the ultrafast, high-yielding formation of two and three disulfide bonds in peptides and proteins. We developed an approach based on the combination of a small molecule, UV-light, and palladium for chemo- and regio-selective activation of Cys, which enables the one-pot formation of multiple disulfide bonds in various peptides and proteins. We prepared bioactive targets of high therapeutic potential, including conotoxin, RANTES, EETI-II, and plectasin peptides and the linaclotide drug. We anticipate that this strategy will be a game-changer in preparing millions of inaccessible targets for drug discovery.
- 8 October 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDe Novo Synthetic Design for Ultrafast Formation of Disulfide Bonds in Peptides and Proteins .pdf
Despite six decades of efforts to synthesize peptides and proteins bearing multiple disulfide bonds, this synthetic challenge remains an unsolved problem in most targets (e.g. knotted mini proteins). Here we show a de novo general synthetic strategy for the ultrafast, high-yielding formation of two and three disulfide bonds in peptides and proteins. We developed an approach based on the combination of a small molecule, UV-light, and palladium for chemo- and regio-selective activation of Cys, which enables the one-pot formation of multiple disulfide bonds in various peptides and proteins. We prepared bioactive targets of high therapeutic potential, including conotoxin, RANTES, EETI-II, and plectasin peptides and the linaclotide drug. We anticipate that this strategy will be a game-changer in preparing millions of inaccessible targets for drug discovery.
- 4 March 2019
- Published by Wiley in Angewandte Chemie
- Vol. 131 (17) , 5785-5789
Palladium‐Mediated Direct Disulfide Bond Formation in Proteins Containing S‐Acetamidomethyl‐cysteine under Aqueous Conditions
One of the applied synthetic strategies for correct disulfide bond formation relies on the use of orthogonal Cys protecting groups. This approach requires purification before and after the deprotection steps, which prolongs the entire synthetic process and lowers the yield of the reaction. A major challenge in using this approach is to be able to apply one‐pot synthesis under mild conditions and aqueous media. In this study, we report the development of an approach for rapid disulfide bond formation by employing palladium chemistry and S‐acetamidomethyl‐cysteine [Cys(Acm)]. Oxidation of Cys(Acm) to the corresponding disulfide bond is achieved within minutes in a one‐pot operation by applying palladium and diethyldithiocarbamate. The utility of this reaction was demonstrated by the synthesis of the peptide oxytocin and the first total chemical synthesis of the protein thioredoxin‐1. Our investigation revealed a critical role of the Acm protecting group in the disulfide bond formation, apparently due to the generation of a disulfiram in the reaction pathway, which significantly assists the oxidation step.
- 4 March 2019
- Published by Wiley in Angewandte Chemie
- Vol. 131 (17) , 5785-5789
Palladium‐Mediated Direct Disulfide Bond Formation in Proteins Containing S‐Acetamidomethyl‐cysteine under Aqueous Conditions
One of the applied synthetic strategies for correct disulfide bond formation relies on the use of orthogonal Cys protecting groups. This approach requires purification before and after the deprotection steps, which prolongs the entire synthetic process and lowers the yield of the reaction. A major challenge in using this approach is to be able to apply one‐pot synthesis under mild conditions and aqueous media. In this study, we report the development of an approach for rapid disulfide bond formation by employing palladium chemistry and S‐acetamidomethyl‐cysteine [Cys(Acm)]. Oxidation of Cys(Acm) to the corresponding disulfide bond is achieved within minutes in a one‐pot operation by applying palladium and diethyldithiocarbamate. The utility of this reaction was demonstrated by the synthesis of the peptide oxytocin and the first total chemical synthesis of the protein thioredoxin‐1. Our investigation revealed a critical role of the Acm protecting group in the disulfide bond formation, apparently due to the generation of a disulfiram in the reaction pathway, which significantly assists the oxidation step.